1. Market Research
  2. > Healthcare Market Trends
  3. > Diagnostics

Medical Diagnostics Industry Overview: Latest Market Reports & Studies

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
44 votes

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider healthcare industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD) and biotech diagnostics, which refers to testing samples of blood, tissue, for example electrocardiography or biopsy for cancer diagnostics; and
  2. Diagnostic imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).
  3. Testing techniques, such as HIV Testing, HPV Testing, Hepatitis Testing or Drug Testing

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Diagnostics Industry Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Medical Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

Customer Support

Talk to Sam

+1 718 303 2384

8500 Reports
Cervical Cancer Screening Coverage, Breast Screening Coverage, Colorectal Cancer Screening Coverage, Diagnostic Revenue
160 Statistics
Diagnostic Reagent Export, Magnetic Resonance Imaging Exams, Computed Tomography Exams Performed, Diagnostic Reagent Import
8700 Reports
Colorectal Cancer Screening Coverage, Breast Screening Coverage, Cervical Cancer Screening Coverage, Diagnostic Revenue
210 Statistics
Computed Tomography Exams Performed, Magnetic Resonance Imaging Exams, Diagnostic Reagent Export, Measuring Equipment Export
2600 Reports
Colorectal Cancer Screening Coverage, Breast Screening Coverage, Cervical Cancer Screening Coverage, Laboratory Expenditure
350 Statistics
Diagnostic Reagent Import, Diagnostic Reagent Export, Measuring Equipment Import, Measuring Equipment Export
5500 Reports
Colorectal Cancer Screening Coverage, Cervical Cancer Screening Coverage, Breast Screening Coverage, Diagnostic Revenue
2000 Reports
Cervical Cancer Screening Coverage, Breast Screening Coverage, Colorectal Cancer Screening Coverage, Laboratory Expenditure
240 Statistics
Diagnostic Reagent Export, Diagnostic Reagent Import, Measuring Equipment Export, Measuring Equipment Import
1100 Reports
Colorectal Cancer Screening Coverage, Breast Screening Coverage, Cervical Cancer Screening Coverage, Laboratory Expenditure
660 Statistics
Diagnostic Expenditure, Health Expenditure, Laboratory Expenditure, Out Of Pocket Expenditure
1200 Reports
Breast Screening Coverage, Colorectal Cancer Screening Coverage, Laboratory Expenditure, Cervical Cancer Screening Coverage
160 Statistics
Diagnostic Reagent Export, Diagnostic Reagent Import, Measuring Equipment Export, Measuring Equipment Import
1200 Reports
Colorectal Cancer Screening Coverage, Cervical Cancer Screening Coverage, Laboratory Expenditure, Breast Screening Coverage
1100 Reports
Colorectal Cancer Screening Coverage, Breast Screening Coverage, Cervical Cancer Screening Coverage, Diagnostic Revenue
200 Statistics
Measuring Equipment Import, Diagnostic Reagent Import, Diagnostic Reagent Export, Measuring Equipment Export
1100 Reports
Cervical Cancer Screening Coverage, Colorectal Cancer Screening Coverage, Breast Screening Coverage, Magnetic Resonance Imaging Exams

About 31000 reports

Purchase Reports From Reputable Market Research Publishers

Transplant Diagnostics Global Market Report 2022

  • $ 5000
  • May 2022
  • 200 pages

Major players in the transplant diagnostics market are Thermo Fisher ScientificInc., Illumina Inc., F. Hoffmann La-Roche AG., Abbott LaboratoriesInc., Qiagen N.V., Immucor Transplant Diagnostics Inc., ...

  • World
  • Western Europe
  • Diagnostics
  • Transplantation
  • Industry analysis

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on